Inter Pharma PCL (BKK:IP)
Thailand flag Thailand · Delayed Price · Currency is THB
4.980
0.00 (0.00%)
Sep 3, 2026, 4:36 PM ICT

Inter Pharma PCL Cash Flow Statement

Millions THB. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
137.98122.3836.6550.79118.88105.22
Depreciation & Amortization
117.01112.66109.5397.1864.4725.67
Other Amortization
4.094.093.051.071.280.93
Loss (Gain) From Sale of Assets
11.61.071.080.470.833.6
Asset Writedown & Restructuring Costs
0.820.820.133.05--
Loss (Gain) From Sale of Investments
11.978.968.143.895.171.8
Loss (Gain) on Equity Investments
1.21.231.592.270.770.08
Provision & Write-off of Bad Debts
-2.77-2.77----
Other Operating Activities
52.1856.631.6522.4431.6516.21
Change in Accounts Receivable
-55.94-15.63-15.63-43.82-43.02-138.36
Change in Inventory
-90.92-31.720.79-24.4-60.61-85.31
Change in Accounts Payable
5853.24-15.8810.1526.3235.21
Change in Other Net Operating Assets
-5.27-3.05-3.25-1.68-2.63-6.62
Operating Cash Flow
239.95307.88177.84121.42143.09-41.57
Operating Cash Flow Growth
0.70%73.13%46.46%-15.14%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-126.39-140.56-237.43-106.46-27.37-224.15
Sale of Property, Plant & Equipment
3.242.391.540.050.252.8
Cash Acquisitions
-1.9-1.9-95.18--538.45-106.57
Sale (Purchase) of Intangibles
-16.43-23.13-24.03-37.63-22.6-13.69
Investment in Securities
-0.28-0.08-0.07-36.32-0.02-10.23
Other Investing Activities
8.41-7.2145.16-52.40.060.06
Investing Cash Flow
-133.34-170.49-310.01-232.77-588.13-351.79

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-41.2239.184520120
Long-Term Debt Issued
-29.8-6200139
Total Debt Issued
32.9471.0239.1851220259
Short-Term Debt Repaid
--1.8-5.4-47.6-112.06-
Long-Term Debt Repaid
--96.17-96.64-171.43-79.68-23.19
Total Debt Repaid
-120.64-97.97-102.04-219.03-191.74-23.19
Net Debt Issued (Repaid)
-87.69-26.95-62.86-168.0328.26235.81
Issuance of Common Stock
00--1,043192.22
Common Dividends Paid
-44.15--12.97-67--4.83
Other Financing Activities
-12.48-14.31-19.62-17.83-23.55-8.28
Financing Cash Flow
-144.33-41.26-95.45-252.861,048414.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.29-0.1-0.170.17-0.26-0.01
Net Cash Flow
-37.4496.04-227.79-364.03602.5621.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
113.56167.33-59.5914.96115.72-265.73
Free Cash Flow Growth
490.42%---87.07%--
Free Cash Flow Margin
5.03%7.56%-3.12%0.83%7.54%-28.85%
Free Cash Flow Per Share
0.190.28-0.100.030.22-0.56
Levered Free Cash Flow
57.9291.71-96.13-52.3739.75-317.63
Unlevered Free Cash Flow
68.64103.95-83.72-36.2754.33-312.62

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
17.0218.8419.6224.0323.057.67
Cash Income Tax Paid
42.8828.7816.4846.7331.5631.08
Change in Working Capital
-94.132.86-13.97-59.75-79.95-195.09